An integrated network-based mechanistic model for tumor growth dynamics under drug administration

Computers in Biology and Medicine

Volumn 39, Issue 4, 2009, Pages 368-384

  Ribeiro, Danilo ^a   Pinto, Jose M ^a  

^a POLYTECHNIC UNIVERSITY   (United States)

Author keywords

Cancer chemotherapy; Cell cycle; Mathematical modeling; Multi scale modeling; p53

Indexed keywords

CANCER CHEMOTHERAPY; CELL CYCLE; MATHEMATICAL MODELING; MULTI SCALE MODELING; P53;

CHEMOTHERAPY; DYNAMICS; PHARMACOKINETICS; TUMORS;

PHYSIOLOGICAL MODELS;

CYCLIN DEPENDENT KINASE; CYCLINE; DOXORUBICIN; PROTEIN MDM2; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE REGULATION; COMPARTMENT MODEL; DRUG ADMINISTRATION ROUTE; MOLECULAR MODEL; MUTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; CELL CYCLE; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DRUG EVALUATION, PRECLINICAL; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MODELS, THEORETICAL; NEOPLASMS; PHARMACOKINETICS; SENSITIVITY AND SPECIFICITY; SOFTWARE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 62749168891     PISSN: 00104825     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compbiomed.2009.01.014     Document Type: Article

References (42)

1. Alarcon T., Byrne H.M., and Maini P.K. A multiple scale model for tumor growth. Multiscale Modeling and Simulation 3 (2005) 440-475
2. Barbolosi D., and Iliadis A. Optimizing drug regimens in cancer chemotherapy: a simulation study using a PK-PD model. Computers in Biology and Medicine 31 3 (2001) 157-172 10.1016/S0010-4825(00)00032-9
3. Bar-Or R.L., Maya R., Segel L.A., Alon U., Levine A.J., and Oren M. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. PNAS 97 (2000) 11250-11255
4. D.S. Brewer, Modelling the p53 gene regulatory network. Doctor of Philosophy Thesis, University of London, London, UK, 2006.
5. Butcher E.C., Berg E.L., and Kundel E.J. System biology in drug discovery. Nature Biotechnology 22 10 (2004) 1253-1259
6. Cardinali M., Jakus J., Shah S., Ensley J.F., Robbins K.C., and Yeudall W.A. p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivo. Oral Oncol. 34 3 (1998) 211-218 10.1016/S1368-8375(97)00083-3
7. V. Chickarmane, A. Nadim, A. Ray, H.M. Sauro, A p53 Oscillator Model of DNA Break Repair Control. arXiv:q-bio.MN/0510002 v1, 2005.
8. Ciliberto A., Novak B., and Tyson J.J. Steady states and oscillations in the p53/Mdm2 network. Cell Cycle 4 (2005) 107-112
9. Csikasz-Nagy A., Battogtokh D., Chen K.C., Novak B., and Tyson J.J. Analysis of a generic model of eukaryotic cell-cycle regulation. Biophysical Journal 90 (2006) 4361-4379
10. De Pillis L.G., and Radunskaya A.E. Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. Journal of Theoretical Biology 238 4 (2006) 841-862 10.1016/j.jtbi.2005.06.037
11. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., and Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacological Reviews 51 4 (1999) 691-743
12. El-Deiry W.S., Tokino T., Waldman T., Oliner J.D., Velculescu V.E., and Burrell M. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Research 55 (1995) 2910-2919
13. Feng S., and Chien S. Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy for cancer and other diseases. Chemical Engineering Science 58 (2003) 4087-4114
14. Gardner S.N. Modeling multi-drug chemotherapy: tailoring treatment to individuals. Journal of Theoretical Biology 214 2 (2002) 181-207 10.1006/jtbi.2001.2459
15. Gartel A.L., and Radhakrishnan S.K. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Research 65 (2005) 3980-3985
16. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
17. Harashima H., Tsuchihashi M., Iida H., Doi H., and Kiwada H. Pharmacokinetic/pharmacodynamic modeling of antitumor agents encapsulated into liposomes. Advanced Drug Delivery Reviews 40 1-2 (1999) 39-61 10.1016/S0169-409X(99)00039-3
18. Harris S.L., and Levine A.J. The p53 pathway: positive and negative feedback loops. Oncogene 24 (2005) 2899-2908
19. Haupt S., Berger M., Goldberg Z., and Haupt Y. Apoptosis-the p53 network. Journal of Cell Science 116 (2003) 4077-4085
20. Hickman E., Moroni M., and Helin K. The role of p53 and pRB in apoptosis and cancer. Current Opinion in Genetics & Development 12 (2002) 60-66
21. Holz M., and Fahr A. Compartment modeling. Advanced Drug Delivery Reviews 48 2-3 (2001) 249-264 10.1016/S0169-409X(01)00118-1
22. Kato S., Han S., Liu W., Otsuja K., Shibata H., and Kanamaru R. Understanding the function-structure and function-mutation relationships p53 tumor suppressor protein by high-resolution missense mutation analysis. PNAS 100 (2003) 8424-8429
23. Kohn K.W. Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Molecular Biology of the Cell 10 (1999) 2703-2734
24. Kozusko F., and Bajzer Z. Combining Gompertzian growth and cell population dynamics. Mathematical Biosciences 185 2 (2003) 153-167 10.1016/S0025-5564(03)00094-4
25. Lane D.P. Cancer. p53, guardian of the genome. Nature 358 (1992) 15-16
26. Lukas J., Gao D., Keshmeshian M., Wen W., Tsao-Wei D., Rosenberg S., and Press M.F. Alernative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer Research 61 (2001) 3213-3219
27. Ma L., Wagner J., Rice J.J., Hu W., Levine A.J., and Stolovitzky G.A. A plausible model for the digital response of p53 to DNA damage. PNAS 102 (2005) 14266-14271
28. Mantzaris N., Webb S., and Othmer H.G. Mathematical modeling of tumor-induced angiogenesis. Journal of Mathematical Biology 8 (2004) 233-257
29. The Mathworks, Inc, Matlab: The Language of Technical Computing, Version 6.5, 2002.
30. Michael D., and Oren M. The p53 and Mdm2 families in cancer. Current Opinion in Genetics & Development 12 (2002) 53-69
31. Munger K., and Howley P.M. Human papillomavirus immortalization and transformation functions. Virus Research 89 2 (2002) 213-228 10.1016/S0168-1702(02)00190-9
32. Novak B., and Tyson J.J. A model for restriction point control of the mammalian cell cycle. Journal of Theoretical Biology 230 4 (2004) 563-579 10.1016/j.jtbi.2004.04.039
33. Ogunnaike B.A. Elucidating the digital control mechanism for DNA damage repair with the p53-Mdm2 system: single cell data analysis and ensemble modelling. Journal of the Royal Society Interface 3 (2005) 175-184
34. Olivier M., Eeles R., Hollstein M., Khan M.A., Harris C.C., and Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Databases Article 19 (2002) 604-614
35. Oren M., Damalas A., Gottlieb T., Michael D., Taplick J., Leal J.F.M., Maya R., Moas M., Seger R., Taya Y., and Ben-Ze' ev A. Regulation of p53: intricate loops and delicate balances. Biochemical Pharmacology 64 5-6 (2002) 865-871 10.1016/S0006-2952(02)01149-8
36. Parker R.S., and Doyle III F.J. Control-relevant modeling in drug delivery. Advanced Drug Delivery Reviews 48 2-3 (2001) 211-228 10.1016/S0169-409X(01)00114-4
37. Parker S.B., Eichele G., Zhang P., Rawls A., Sands A.T., and Bradley A. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267 (1995) 1024-1027
38. Ribba B., Colin T., and Schnell S. A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies. Theoretical Biology and Medical Modelling 3 7 (2006) 1-19
39. Soussi T., Kato S., Levy P.P., and Ishioka C. Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations. Human Mutation 25 (2005) 6-17
40. Vogelstein B., Lane D., and Levine A. Surfing the p53 network. Nature 408 (2000) 307-310
41. WAF1 control of epithelial cell cycle and cell fate. Critical Reviews in Oral Biology & Medicine 13 (2002) 453-464
42. D. Zak, G.E. Gonye, J.S. Schwaber, F.J. Doyle III, Importance of input perturbations and stochastic gene expression in the reverse engineering of genetic regulatory networks: insights from an identifiability analysis of an in silico network, Genome Research 13 (2003) 2396-2405.